Celebrex and bextra

Pfizer To Pay $486M To Settle Celebrex, Bextra Securities MDL.

N) on Tuesday said it has reached a $486 million settlement of litation accusing it of causing b losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs.

Million Nationwide Class Action Settlement Approved in Bextra.

Pfizer, the world’s largest drug company, has agreed in principle to an $894 settlement for the painers, Celebrex and Bextra.

<strong>Celebrex</strong>, Vioxx <strong>and</strong> <strong>Bextra</strong> News -

Celebrex, Vioxx and Bextra News -

The settlement resolves a lawsuit filed by investors in 2004 accusing the company of leaving them in the dark about risks associated with Celebrex and Bextra, Reuters reports.

Pfizer $900 Million Celebrex Bextra Settlement

Law360, New York (August 2, 2016, PM EDT) -- Pfizer Inc.


Celebrex and bextra:

Rating: 100 / 100

Overall: 98 Rates